The integrin αvβ6 is a promising therapeutic target for treating PDAC
dc.contributor.author | Marshall, J | en_US |
dc.contributor.author | Vallath, S | en_US |
dc.contributor.author | Reader, C | en_US |
dc.contributor.author | Morton, J | en_US |
dc.contributor.author | Sansom, O | en_US |
dc.contributor.author | Evans, TRJ | en_US |
dc.contributor.author | Biankin, A | en_US |
dc.contributor.author | Kocher, HM | en_US |
dc.date.accessioned | 2020-09-08T14:45:47Z | |
dc.date.issued | 2016-06-01 | en_US |
dc.identifier.issn | 1424-3903 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/66873 | |
dc.format.extent | s6 - ? | en_US |
dc.relation.ispartof | Pancreatology | en_US |
dc.title | The integrin αvβ6 is a promising therapeutic target for treating PDAC | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1016/j.pan.2016.04.023 | en_US |
pubs.issue | 3 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 16 | en_US |
qmul.funder | Development of imaging and therapy of pancreatic cancer by targeting the integrin αvβ6::Pancreatic Cancer Research Fund | en_US |
qmul.funder | Development of imaging and therapy of pancreatic cancer by targeting the integrin αvβ6::Pancreatic Cancer Research Fund | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |